Get the Stockscreener App
1.21
11.01%
0.12
After Hours:
1.20
-0.01
-0.83%
Lucid Diagnostics Inc stock is traded at $1.21, with a volume of 781.64K.
It is up +11.01% in the last 24 hours and down -17.69% over the past month.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
781.64K
Relative Volume:
0.91
Market Cap:
$125.10M
Revenue:
$4.35M
Net Income/Loss:
$-45.53M
P/E Ratio:
-1.1204
EPS:
-1.08
Net Cash Flow:
$-44.79M
1W Performance:
-3.20%
1M Performance:
-17.69%
6M Performance:
+44.77%
1Y Performance:
+50.85%
1-Day Range:
$1.09
$1.235
1-Week Range:
$1.07
$1.2593
52-Week Range:
$0.6301
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics Inc
Sector
Industry
Phone
212 949 4319
Address
360 MADISON AVENUE, NEW YORK
Compare LUCD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.21 | 125.10M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-21 | Initiated | Ascendiant Capital Markets | Buy |
| Nov-08-21 | Initiated | BTIG Research | Buy |
| Nov-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-08-21 | Initiated | Needham | Buy |
Lucid Diagnostics Inc Stock (LUCD) Latest News
Lucid Diagnostics finalizes public offering of common stock - Medical Buyer
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - The Bradford Era
Lucid Diagnostics Closes $16.1 Million Public Offering - MSN
Lucid Diagnostics completes $16.1 million stock offering By Investing.com - Investing.com South Africa
Lucid Diagnostics Raises $16.1 Mln Through Public Offering To Support Corporate Growth - Nasdaq
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc (LUCD) With A Potential Upside Of More Than -100.0% - stocksregister.com
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - GuruFocus
Lucid Diagnostics completes $16.1 million stock offering - Investing.com
Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock - marketscreener.com
Lucid Diagnostics Raises $16.1M: Cancer Detection Company Strengthens Financial Position - Stock Titan
Indo-Asian News Service - Indo-Asian News Service (IANS)
Lucid Diagnostics Shares Fall After Pricing Stock Offering - marketscreener.com
Lucid Diagnostics Announces Public Stock Offering - TipRanks
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Lucid Diagnostics Announces Proposed Public Offering of Common Stock - The Malaysian Reserve
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock - MarketScreener
Medical Diagnostics Pioneer Lucid Secures $15M Strategic Financing Round - Stock Titan
Lucid Diagnostics plans stock offering to boost capital By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces Proposed Public Offering of Common S - GuruFocus
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics plans stock offering to boost capital - Investing.com Australia
Lucid Diagnostics Announces Proposed Public Offering Of Common Stock - MarketScreener
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Lucid Diagnostics stock soars to 52-week high of $1.64 - Investing.com Australia
Lucid Diagnostics stock soars to 52-week high of $1.64 By Investing.com - Investing.com South Africa
Pavmed Inc Files For Offering Of 3.3 Million Shares Of Common Stock - marketscreener.com
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Lucid Diagnostics to Participate in Fireside Chat at the 24th An - GuruFocus
PAVmed outlines strategic milestones for 2025, including Veris implantable device submission - MSN
Pavmed’s Strategic Growth and Financial Challenges - MSN
[New] Lucid Stock Price Prediction 2024, 2025 To 2050 - Exla Resources
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Game-Changing Cancer Detection: EsoCheck Achieves 99% Accuracy Across 30,000 Patient Study - Stock Titan
Cantor Fitzgerald maintains Lucid Diagnostics stock at overweight By Investing.com - Investing.com Canada
Analysts Are Bullish on Top Healthcare Stocks: Quince Therapeutics (QNCX), Lucid Diagnostics (LUCD) - The Globe and Mail
Cantor Fitzgerald maintains Lucid Diagnostics stock at overweight - Investing.com India
PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability - Yahoo
PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com
Lucid Diagnostics Inc Stock (LUCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):